Cargando…
Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?
SIMPLE SUMMARY: Endometrial carcinomas (EC) have been traditionally classified based on histopathology (types I and II). Determining the risk of a patient to experience disease recurrence is important to decide which patients need adjuvant treatment. The current endometrial carcinoma risk assessment...
Autores principales: | Baiden-Amissah, Regina Esi Mensimah, Annibali, Daniela, Tuyaerts, Sandra, Amant, Frederic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391655/ https://www.ncbi.nlm.nih.gov/pubmed/34439142 http://dx.doi.org/10.3390/cancers13163988 |
Ejemplares similares
-
Contribution of Aging, Obesity, and Microbiota on Tumor Immunotherapy Efficacy and Toxicity
por: Baiden-Amissah, Regina E. M., et al.
Publicado: (2019) -
Endometrial Stromal Sarcomas: A Revision of Their Potential as Targets for Immunotherapy
por: Tuyaerts, Sandra, et al.
Publicado: (2018) -
Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?
por: De Wispelaere, Wout, et al.
Publicado: (2021) -
The Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial Cancer
por: Marinelli, Oliviero, et al.
Publicado: (2020) -
Biological Function of PD-L2 and Correlation With Overall Survival in Type II Endometrial Cancer
por: Marinelli, Oliviero, et al.
Publicado: (2020)